Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders Myeloma Canada Research Network Consensus Guideline Consortium Recommendations

Multiple myeloma (MM) is a plasma cell (PC) malignancy of terminally differentiated B lymphocytes that is typically associated with the secretion of partial and/or complete monoclonal immunoglobulins and a constellation of particular symptoms and signs. MM is a treatable condition and timely diagnosis is essential to limit or avoid irreversible target-organ damage and to prolong survival.The Myeloma Canada Research Network Consensus Guideline Consortium (MCRN-CGC) proposes national consensus recommendations for the diagnosis of MM and associated PC neoplasms.

Source: Clinical Lymphoma, Myeloma and Leukemia - February 2, 2020 Category: Hematology Authors: Myeloma Canada Research Network Consensus Guideline Consortium (alphabetical order), Debra J. Bergstrom, Rami Kotb, Martha L. Louzada, Heather J. Sutherland, Sofia Tavoularis, Christopher P. Venner Tags: Review Article Source Type: research